PLoS ONE · 2014 · 32 citations · 32 references
MedicineCancer BiologyOncologyCell SignalingMolecular OncologySignal TransductionCancer Cell SignalingCancer ProgressionHepatocellular CarcinomaLiver CancerOncogenic Signaling PathwaysSignal Transduction In CancerCancer Signaling PathwaysCaveolin ProteinsCrosstalkHepatocellular Carcinoma PathogenesisHepatocyte Growth Factor Receptor SignalingHepatocyte Growth Factor SignalingOncogenic Signaling NetworksSignal Transduction Alteration
c-Met, the receptor for Hepatocyte Growth Factor (HGF), overexpressed and deregulated in Hepatocellular Carcinoma (HCC). Caveolin 1 (CAV1), a plasma membrane protein that modulates signal transduction molecules, is also overexpressed in HCC. The aim of this study was to investigate biological and clinical significance of co-expression and activation of c-Met and CAV1 in HCC. We showed that c-Met and CAV1 were co-localized in HCC cells and HGF treatment increased this association. HGF-triggered c-Met activation caused a concurrent rise in both phosphorylation and expression of CAV1. Ectopic expression of CAV1 accelerated c-Met signaling, resulted in enhanced migration, invasion, and branching-morphogenesis. Silencing of CAV1 downregulated c-Met signaling, and decreased migratory/invasive capability of cells and attenuated branching morphogenesis. In addition, activation and co-localization of c-Met and CAV1 were elevated during hepatocarcinogenesis. In conclusion reciprocal activating crosstalk between c-Met and CAV1 promoted oncogenic signaling of c-Met contributed to the initiation and progression of HCC.
32
Hyangkyu Lee, Daniela Volonté, Ferruccio Galbiati et al. · Molecular Endocrinology · 2000 · 321 citations · Full text